ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EB02 | G | Erlotinib (HCl) - 150mg | 10565/945 | 23118/1 | TARESSA 150 | 150mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Manufactured by Hetero Labs Ltd, India for Benta SAL | Lebanon | 98,617,813 L.L | 2.44 | E2 | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EB02 | B | Erlotinib (HCl) - 150mg | 5561 | 222249/08 | TARCEVA | 150mg | 30 | Tablet, film coated | Oral | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 2,425,421 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | |
L01EB02 | B | Erlotinib (HCl) - 150mg | 7631 | 97509/11 | TARCEVA | 150mg | 30 | Tablet, film coated | Oral | Omnipharma | Delpharm Milano SRL | Italy | 2,295,741 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | |
L01EB02 | G | Erlotinib (HCl) - 150mg | 10820 | 145320/1 | APO-ERLOTINIB | 150mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 1,528,491 L.L | 2.44 | E2 | Apotex Inc | Canada | 2/5/2024 | |
L01EB02 | G | Erlotinib (HCl) - 150mg | 10032 | 112916/1 | MIRATA | 150mg | 30 | Tablet, film coated | Oral | Droguerie Mercury S.A.L. | The Arab Pharmaceutical Manufacturing PSC | Jordan | 1,455,261 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | |
L01EB02 | G | Erlotinib (HCl) - 150mg | 10565 | 23118/1 | TARESSA 150 | 150mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Manufactured by Hetero Labs Ltd, India for Benta SAL | Lebanon | 1,661,077 L.L | 2.44 | E2 | 2/5/2024 | |||
L01EB02 | B | Erlotinib (HCl) - 150mg | 5561/945 | 222249/08 | TARCEVA | 150mg | 30 | Tablet, film coated | Oral | Omnipharma | F. Hoffmann La Roche Ltd | Switzerland | 147,869,593 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
L01EB02 | B | Erlotinib (HCl) - 150mg | 7631/945 | 97509/11 | TARCEVA | 150mg | 30 | Tablet, film coated | Oral | Omnipharma | Delpharm Milano SRL | Italy | 139,963,417 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
L01EB02 | G | Erlotinib (HCl) - 150mg | 10820/945 | 145320/1 | APO-ERLOTINIB | 150mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 93,186,892 L.L | 2.44 | E2 | Apotex Inc | Canada | 2/5/2024 | 0 |
L01EB02 | G | Erlotinib (HCl) - 150mg | 10032/945 | 112916/1 | MIRATA | 150mg | 30 | Tablet, film coated | Oral | Droguerie Mercury S.A.L. | The Arab Pharmaceutical Manufacturing PSC | Jordan | 88,722,301 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |